ADVACAN 0.5MG TABLET

Advacan 0.5mg Tablet is an immunosuppressant medication used to prevent organ rejection in patients who have undergone kidney or liver transplantation. It contains everolimus, a well-established mTOR inhibitor that helps control the body’s immune response. By reducing immune activity, this medicine supports the long-term success of transplant procedures when taken as prescribed by a healthcare professional.

Advacan 0.5mg Tablet works by blocking specific proteins responsible for cell growth and immune activation. This action helps prevent the immune system from attacking the transplanted organ. It is commonly used in combination with other immunosuppressive medicines to enhance treatment effectiveness and reduce the risk of rejection.

Advacan 0.5mg Tablet ensures safety, consistency, and reliable therapeutic outcomes. It is widely supplied to hospitals, pharmacies, and global pharmaceutical markets. Regular monitoring and medical supervision are essential while using this medication for optimal results.

Product Features

• Contains Everolimus 0.5mg
• Prevents organ rejection after transplantation
• mTOR inhibitor for controlled immune response
• Suitable for long-term transplant management
• High-quality pharmaceutical formulation

How It helps

• Reduces risk of organ rejection
• Controls overactive immune response
• Supports transplant success
• Works effectively in combination therapy